Tüzün B.Saygin A.Wolf R.Özdemir M.Tüzün Y.2024-06-122024-06-1220020738-081Xhttps://doi.org/10.1016/S0738-081X(02)00288-2https://hdl.handle.net/20.500.14551/16189[No abstract available]en10.1016/S0738-081X(02)00288-2info:eu-repo/semantics/closedAccessAciclovir; Adrenalin; Carcinogen; Cimetidine; Dichloroacetic Acid; Dna Vaccine; Famciclovir; Fluorouracil; Foscarnet; Gamma Interferon; Imiquimod; Inactivated Vaccine; Interferon; Kaemphenol; Lindane; Liquid Nitrogen; Mutagenic Agent; Peptide Derivative; Podophyllin; Podophyllotoxin; Quercetin; Recombinant Dna; Resin; Resiquimod; Trichloroacetic Acid; Unclassified Drug; Unindexed Drug; Vaccine; Valaciclovir; Virus Vaccine; Zidovudine; Anus Disease; Bladder Cancer; Blister; Bone Marrow Suppression; Carbon Dioxide Laser; Clinical Trial; Coma; Condyloma; Cryotherapy; Drug Approval; Drug Cost; Drug Efficacy; Drug Research; Drug Screening; Drug Synthesis; Electrosurgery; Erosion; Erythema; Excision; Gel; Genital Herpes; Genital System Disease; Human; Hygiene; Hypokalemia; Infection Control; Infestation; Molluscum Contagiosum; Nonhuman; Pain; Peripheral Neuropathy; Priority Journal; Pubic Pediculosis; Recurrent Disease; Review; Scabies; Side Effect; Skin Irritation; Skin Manifestation; Tincture; Ulcer; Virus InfectionArticle2066686712-s2.0-003686420312490361Q2